跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dienogest/Ethinylestradiol
首页
药物
Dienogest/Ethinylestradiol
Dienogest/Ethinylestradiol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NEW MODIFIED RELEASE ORAL CONTRACEPTIVE COMPOSITION
EP 3954364 A1
申请人: CHEMO RES S L
优先权: 2020
EP
US
WO
8 件公开
PHARMACEUTICAL PRODUCT CONTAINING PROGESTIN, GENISTEIN, AND VITAMIN D COMPOUND
US 2008167276 A1
申请人: RODRIGUEZ GUSTAVO C
优先权: 2007
US
3 件公开
METHODS OF ORAL CONTRACEPTION BY CONTROLLED RELEASE OF DIENOGEST AND ETHYNYL ESTRADIOL
US 20260021110 A1
申请人: CHEMO RES S L
优先权: 2024
US
WO
2 件公开
Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
US 2005282790 A1
申请人: NASHED NORMAN
优先权: 2005
US
2 件公开
ORAL CONTRACEPTION (LONG-CYCLE REGIMEN AND 21-DAYS-REGIMEN WITH 30 MG ETHINYLESTRADIOL AND 2 MG DIENOGEST) WITHOUT TREATMENT OF THROMBOSIS/HEMOSTASIS
US 2009099144 A1
申请人: MITTMANN KATRIN
优先权: 2008
US
2 件公开
Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception
US 2009117184 A1
申请人: FRICKE SABINE
优先权: 2008
US
2 件公开
Peroral solid dosage form for contraception comprising Dienogest and Ethinylestradiol
EP 1690529 A1
申请人: SCHERING AG
优先权: 2005
EP
Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
CN 101489563 A
申请人: BAYER SCHERING PHARMA AG
优先权: 2006
CN
Contraceptive compositions for decrease risk of inborn errors
EP 1891959 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2006
EP
Method for manufacturing a single-phase pharmaceutical preparation for oral treatment to regulate blood pressure
EP 2020235 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2007
EP
第 1 / 2 页
上一页
下一页
药物
反馈